U.S. clears way for drugmakers to share COVID antibody capacity – Reuters

U.S. clears way for drugmakers to share COVID antibody capacity – Reuters

The U.S. Department of Justice on Thursday said it will not stand in the way of efforts by companies, including Eli Lilly and Co and Amgen Inc, to share information to help scale up capacity to manufacture antibody treatments for COVID-19, the disease caused …

Read More…

You May Also Like